Concurrent Ipilimumab and Stereotactic Ablative Radiation Therapy (SART) for Oligometastatic But Unresectable Melanoma

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2014 by Comprehensive Cancer Centers of Nevada
Sponsor:
Collaborator:
Comprehensive Cancer Centers of Nevada
Information provided by (Responsible Party):
Wolfram Samlowski, Comprehensive Cancer Centers of Nevada
ClinicalTrials.gov Identifier:
NCT01565837
First received: March 26, 2012
Last updated: February 5, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2015
  Estimated Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)